US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Candel Therapeutics, Inc.

4.51

-0.0600-1.31%

Post-market: 4.540.0300+0.67%19:45 EDT

Volume:385.55K

Turnover:1.75M

Market Cap:213.03M

PE:-2.59

High:4.81

Open:4.48

Low:4.41

Close:4.57

Loading ...

Overview Company News Filings

Promising Clinical Outcomes and Strategic Advances Boost Candel Therapeutics’ CAN-2409 Potential in Oncology

Candel Therapeutics Announces Publication of Phase 1b Clinical Trial Data on the Combination of CAN-2409 and Nivolumab plus Standard of Care in Newly Diagnosed High-Grade Glioma Patients

Candel Therapeutics Reports Prolonged Survival In Mid-Stage Study For Pretreated Lung Cancer Patients

Promising CAN-2409 Trial Results Drive Buy Rating for Candel Therapeutics

Candel Therapeutics Reports Final Phase 2a Survival Data for Lung Cancer Treatment

MT Newswires Live

Candel Therapeutics Reports Both Prolonged Median Overall Survival And Long Tail Of Survival In Phase 2A Clinical Trial Of CAN-2409 In Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Non-Re

Candel Therapeutics Inc: Can-2409 Continued to Exhibit a Generally Favorable Safety and Tolerability Profile Throughout Extended Follow-up Period

THOMSON REUTERS

Candel Therapeutics: Statistically Significant Improved Overall Survival in Non-Squamous Nsclc VS Squamous Nsclc After Can-2409 Experimental Treatment

THOMSON REUTERS

Candel Therapeutics Reports Both Prolonged Median Overall Survival and Long Tail of Survival in Phase 2a Clinical Trial of Can-2409 in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients Non-Responsive to Immune Checkpoint Inhibitor (Ici) Treatment

THOMSON REUTERS

Candel Therapeutics Reports Both Prolonged Median Overall Survival and Long Tail of Survival in Phase 2a Clinical Trial of CAN-2409 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment

Candel Therapeutics Partners With IDEA Pharma for CAN-2409 Commercialization

MT Newswires Live

Candel Therapeutics and Idea Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for Can-2409

THOMSON REUTERS

Candel Therapeutics Inc - Partnership With Idea Pharma Expected to Run Through 2026

THOMSON REUTERS

Candel Therapeutics and IDEA Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for CAN-2409

Candel Therapeutics Appoints Renowned Pancreatic Cancer Expert, Elizabeth M. Jaffee, M.D., to Research Advisory Board

Candel Therapeutics Price Target Maintained With a $19.00/Share by HC Wainwright & Co.

Promising Clinical Results and Strong Potential of Candel Therapeutics’ CAN-2409 Justify Buy Rating

BRIEF-Candel Therapeutics Q4 Net Income USD -14.073 Million

Candel Therapeutics Q4 Net Income USD -14.073 Million

THOMSON REUTERS

Press Release: Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CADL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CADL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CADL\",,,,,undefined,":{"symbol":"CADL","market":"US","secType":"STK","nameCN":"Candel Therapeutics, Inc.","latestPrice":4.51,"timestamp":1745265600000,"preClose":4.57,"halted":0,"volume":385546,"hourTrading":{"tag":"盘后","latestPrice":4.54,"preClose":4.51,"latestTime":"19:45 EDT","volume":4865,"amount":21946.24,"timestamp":1745279150927},"delay":0,"floatShares":35925973,"shares":47235460,"eps":-1.741968,"marketStatus":"Closed","change":-0.06,"latestTime":"04-21 16:00:00 EDT","open":4.48,"high":4.81,"low":4.41,"amount":1750201.874386,"amplitude":0.087527,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.741968,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":5,"adr":0,"listingDate":1627358400000,"exchange":"NASDAQ","adjPreClose":4.57,"preHourTrading":{"tag":"盘前","latestPrice":4.76,"preClose":4.57,"latestTime":"08:15 EDT","volume":23,"amount":107.090001,"timestamp":1745237750535},"postHourTrading":{"tag":"盘后","latestPrice":4.54,"preClose":4.51,"latestTime":"19:45 EDT","volume":4865,"amount":21946.24,"timestamp":1745279150927},"volumeRatio":0.626524,"impliedVol":0.2218,"impliedVolPercentile":0.02},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CADL\",,,,,undefined,":{"symbol":"CADL","floatShares":35925973,"roa":"-27.55%","roe":"-139.56%","lyrEps":-1.741968,"volumeRatio":0.626524,"shares":47235460,"dividePrice":0,"high":4.81,"amplitude":0.087527,"preClose":4.57,"low":4.41,"week52Low":3.785,"pbRate":"3.21","psRate":"6872.00","week52High":14.6,"institutionHeld":0,"latestPrice":4.51,"eps":-1.741968,"divideRate":0,"volume":385546,"delay":0,"ttmEps":-1.741968,"open":4.48,"prevYearClose":8.68,"prevWeekClose":4.57,"prevMonthClose":5.65,"prevQuarterClose":5.65,"fiveDayClose":4.97,"twentyDayClose":8.06,"sixtyDayClose":7.06},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CADL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526512486","title":"Promising Clinical Outcomes and Strategic Advances Boost Candel Therapeutics’ CAN-2409 Potential in Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2526512486","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526512486?lang=en_us&edition=fundamental","pubTime":"2025-04-11 18:35","pubTimestamp":1744367732,"startTime":"0","endTime":"0","summary":"Analyst Vernon Bernardino of H.C. Wainwright reiterated a Buy rating on Candel Therapeutics (CADL – Research Report), retaining the price target of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-clinical-outcomes-and-strategic-advances-boost-candel-therapeutics-can-2409-potential-in-oncology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-clinical-outcomes-and-strategic-advances-boost-candel-therapeutics-can-2409-potential-in-oncology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4595","LENZ","BK4526","BK4139","CADL","BK4600","BK4007","BK4170"],"gpt_icon":0},{"id":"2524186551","title":"Candel Therapeutics Announces Publication of Phase 1b Clinical Trial Data on the Combination of CAN-2409 and Nivolumab plus Standard of Care in Newly Diagnosed High-Grade Glioma Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2524186551","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524186551?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:01","pubTimestamp":1743508860,"startTime":"0","endTime":"0","summary":"Data published in Neuro-Oncology demonstrate promising safety profile and potential survival benefit when combining CAN-2409 and nivolumab with standard of careNEEDHAM, Mass., April  01, 2025  (GLOBE ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/01/3053320/0/en/Candel-Therapeutics-Announces-Publication-of-Phase-1b-Clinical-Trial-Data-on-the-Combination-of-CAN-2409-and-Nivolumab-plus-Standard-of-Care-in-Newly-Diagnosed-High-Grade-Glioma-Pa.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CADL","LU0053666078.USD","MGMT","SMP","BK4588","L","BK4170","LENZ","BK4526","BK4107","BK4539","BK4585","BK4124","BK4600","BK4595"],"gpt_icon":1},{"id":"2522532234","title":"Candel Therapeutics Reports Prolonged Survival In Mid-Stage Study For Pretreated Lung Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2522532234","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522532234?lang=en_us&edition=fundamental","pubTime":"2025-03-28 03:46","pubTimestamp":1743104775,"startTime":"0","endTime":"0","summary":"Candel Therapeutics, Inc.  on Wednesday revealed final survival data from a phase 2a trial of CAN-2409 in patients with stage III/IV NSCLC, inadequately responding to Immune Checkpoint Inhibitor  treatment.The median overall survival  was 24.5 months in 46 evaluable patients receiving 2 courses of CAN-2409 and 21.5 months in evaluable patients from cohort 2  that presented with progressive disease at baseline, despite ICI treatment.The company on Wednesday said mOS in patients with progressive disease despite ICI treatment was 9.8-11.8 months in other studies, including those with standard of care of docetaxel chemotherapy.This final analysis included extended follow-up data , with a median follow-up time for the per-protocol population of 32.4 months.Data showed a sizable percentage of patients with survival exceeding 24 months, evidence of a long tail of survival, with 37% of patients with progressive disease despite treatment with ICI alive 2 years after CAN-2409 administration.Biom","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/candel-therapeutics-reports-prolonged-survival-194615613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4170","LENZ","BK4139","BK4107","SSI","L","LU0053666078.USD","BK4595","CADL","BK4526","BK4600","BK4588","BK4539"],"gpt_icon":1},{"id":"2522137594","title":"Promising CAN-2409 Trial Results Drive Buy Rating for Candel Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2522137594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522137594?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:55","pubTimestamp":1743072940,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst John Newman has maintained their bullish stance on CADL stock, giving a Buy rating on March 20. John Newman has given his...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-can-2409-trial-results-drive-buy-rating-for-candel-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-can-2409-trial-results-drive-buy-rating-for-candel-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","CADL"],"gpt_icon":0},{"id":"2522635911","title":"Candel Therapeutics Reports Final Phase 2a Survival Data for Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2522635911","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522635911?lang=en_us&edition=fundamental","pubTime":"2025-03-27 05:40","pubTimestamp":1743025228,"startTime":"0","endTime":"0","summary":"Candel Therapeutics  said Wednesday it released final survival data from its phase 2a trial of CAN-2409 in advanced non-small cell lung cancer patients resistant to immune checkpoint inhibitor treatment.The study demonstrated positive results, with a median overall survival of 24.5 months in the evaluable patients, surpassing standard care outcomes.Key findings include a median overall survival of 21.5 months in patients with progressive disease despite ICI therapy, compared to 9.8 to 11.8 months with standard docetaxel chemotherapy. Additionally, 37% of patients survived beyond two years after receiving CAN-2409, while 69% showed regression in uninjected tumors, demonstrating an abscopal effect. Non-squamous NSCLC patients had the best outcomes, with a median overall survival of 25.4 months, the company said.Throughout the long-term study, CAN-2409 maintained a strong safety profile and was well-tolerated by patients, Candel Therapeutics said.Candel shares rose 2.5% in after-hours tra","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","CADL","BK4539","BK4139"],"gpt_icon":0},{"id":"2522587133","title":"Candel Therapeutics Reports Both Prolonged Median Overall Survival And Long Tail Of Survival In Phase 2A Clinical Trial Of CAN-2409 In Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Non-Re","url":"https://stock-news.laohu8.com/highlight/detail?id=2522587133","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522587133?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:30","pubTimestamp":1743021030,"startTime":"0","endTime":"0","summary":"March 26 (Reuters) - Candel Therapeutics Inc ::*CANDEL THERAPEUTICS REPORTS BOTH PROLONGED MEDIAN OVERALL SURVIVAL AND LONG TAIL OF SURVIVAL IN PHASE 2A CLINICAL TRIAL OF CAN-2409 IN ADVANCED NON-SMAL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nRSD24MJ6z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CADL","BK4539"],"gpt_icon":0},{"id":"2522330732","title":"Candel Therapeutics Inc:  Can-2409 Continued to Exhibit a Generally Favorable Safety and Tolerability Profile Throughout Extended Follow-up Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2522330732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522330732?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:10","pubTimestamp":1743019830,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q91CP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CADL","BK4539","BK4139"],"gpt_icon":0},{"id":"2522307553","title":"Candel Therapeutics: Statistically Significant Improved Overall Survival in Non-Squamous Nsclc VS Squamous Nsclc After Can-2409 Experimental Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2522307553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522307553?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:10","pubTimestamp":1743019830,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q91CP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","CADL"],"gpt_icon":0},{"id":"2522302923","title":"Candel Therapeutics Reports Both Prolonged Median Overall Survival and Long Tail of Survival in Phase 2a Clinical Trial of Can-2409 in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients Non-Responsive to Immune Checkpoint Inhibitor (Ici) Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2522302923","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522302923?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:10","pubTimestamp":1743019830,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q91CP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CADL","BK4539","BK4139"],"gpt_icon":0},{"id":"2522534823","title":"Candel Therapeutics Reports Both Prolonged Median Overall Survival and Long Tail of Survival in Phase 2a Clinical Trial of CAN-2409 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2522534823","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522534823?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:05","pubTimestamp":1743019500,"startTime":"0","endTime":"0","summary":"Experimental treatment with CAN-2409 was associated with a median overall survival  of 24.5 months in patients with advanced NSCLC who had an inadequate response to ICI treatment, failed several chemotherapy regimens, and presented with multiple negative prognostic factors at enrollment . mOS of 21.5 months was observed in patients with progressive disease at baseline despite ICI therapy , markedly exceeding mOS which has been reported in published literature for this population with standard of care of docetaxel chemotherapy . Long tail of survival observed in 37%  of patients with progressive disease despite ICI treatment at enrollment, who were still alive more than 2 years after CAN-2409 administration at the time of data cutoff ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/candel-therapeutics-reports-both-prolonged-200500872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4595","BK4107","IE00B19Z4B17.USD","LU0053666078.USD","BK4139","BK4588","BK4157","BK4526","BK4600","BK4539","LU0053671581.USD","CADL","IE00B66KJ199.SGD","BK4585","IE0031619046.USD","AEIS","BK4170","BK4161","IE00B7SZL793.SGD","LU0054578231.USD","ITT","LENZ","L"],"gpt_icon":1},{"id":"2520568974","title":"Candel Therapeutics Partners With IDEA Pharma for CAN-2409 Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2520568974","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520568974?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:28","pubTimestamp":1742473717,"startTime":"0","endTime":"0","summary":"Candel Therapeutics  and IDEA Pharma said Thursday they have entered a commercial partnership to support the development and potential market launch of Candel's lead candidate CAN-2409.As part of the agreement, set to continue through next year, IDEA will provide strategic guidance as Candel prepares a biologics license application for CAN-2409 in prostate cancer, the companies said.The partnership follows encouraging late-stage results showing the treatment improved disease-free survival and reduced recurrence, the companies said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4135","IDEA","CADL","LENZ","BK4539","BK4139"],"gpt_icon":1},{"id":"2520531804","title":"Candel Therapeutics and Idea Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for Can-2409","url":"https://stock-news.laohu8.com/highlight/detail?id=2520531804","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520531804?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:00","pubTimestamp":1742472003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA3Q2QBM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CADL","BK4539","BK4139"],"gpt_icon":0},{"id":"2520453460","title":"Candel Therapeutics Inc - Partnership With Idea Pharma Expected to Run Through 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2520453460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520453460?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:00","pubTimestamp":1742472003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA3Q2QBM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","CADL"],"gpt_icon":0},{"id":"2520453781","title":"Candel Therapeutics and IDEA Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for CAN-2409","url":"https://stock-news.laohu8.com/highlight/detail?id=2520453781","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520453781?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:00","pubTimestamp":1742472000,"startTime":"0","endTime":"0","summary":"NEEDHAM, Mass., March  20, 2025  (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biolo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/20/3046172/0/en/Candel-Therapeutics-and-IDEA-Pharma-Announce-Strategic-Partnership-to-Advance-Path-to-Market-Commercialization-Efforts-for-CAN-2409.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","BK4585","L","LENZ","BK4139","LU0053666078.USD","BK4135","BK4170","IDEA","BK4595","BK4539","CADL","BK4588","BK4600","BK4526"],"gpt_icon":1},{"id":"2520675088","title":"Candel Therapeutics Appoints Renowned Pancreatic Cancer Expert, Elizabeth M. Jaffee, M.D., to Research Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2520675088","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520675088?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:00","pubTimestamp":1742299200,"startTime":"0","endTime":"0","summary":"NEEDHAM, Mass., March 18, 2025  -- Candel Therapeutics, Inc.  , a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the appointment of Elizabeth M. Jaffee, M.D., to the Company's Research Advisory Board . Dr. Jaffee, an internationally recognized expert in cancer immunology and pancreatic cancer, brings her extensive expertise to the RAB, which is important in light of the Company’s focus on borderline resectable pancreatic cancer.Candel is a clinical stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. Candel has established two clinical stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and Herpes simplex virus  gene constructs, respectively. CAN-2409 is the lead product candidate from the a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/candel-therapeutics-appoints-renowned-pancreatic-120000386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CADL","BK4595","LENZ","BK4139","BK4170","BK4526","BK4600"],"gpt_icon":1},{"id":"2519382248","title":"Candel Therapeutics Price Target Maintained With a $19.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2519382248","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519382248?lang=en_us&edition=fundamental","pubTime":"2025-03-15 00:29","pubTimestamp":1741969740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CADL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 14, 2025 12:29 ET (16:29 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CADL"],"gpt_icon":0},{"id":"2519480791","title":"Promising Clinical Results and Strong Potential of Candel Therapeutics’ CAN-2409 Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2519480791","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519480791?lang=en_us&edition=fundamental","pubTime":"2025-03-14 21:35","pubTimestamp":1741959314,"startTime":"0","endTime":"0","summary":"In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Candel Therapeutics (CADL – Research Report), with a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-clinical-results-and-strong-potential-of-candel-therapeutics-can-2409-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-clinical-results-and-strong-potential-of-candel-therapeutics-can-2409-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","CADL"],"gpt_icon":0},{"id":"2519286944","title":"BRIEF-Candel Therapeutics Q4 Net Income USD -14.073 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2519286944","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519286944?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:15","pubTimestamp":1741896945,"startTime":"0","endTime":"0","summary":"BRIEF-Candel Therapeutics Q4 Net Income USD -14.073 Million\n\n\nMar 13 (Reuters) - Candel Therapeutics Q4 income from operations USD -8.141 million vs. IBES estimate USD -9.57 million.\n\nQ4 basic EPS USD -0.4\nQ4 operating expenses USD 8.141 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nPLX07249F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CADL"],"gpt_icon":0},{"id":"2519869194","title":"Candel Therapeutics Q4 Net Income USD -14.073 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2519869194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519869194?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:15","pubTimestamp":1741896900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nPLX07249F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CADL","BK4539","BK4139"],"gpt_icon":0},{"id":"2519586929","title":"Press Release: Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2519586929","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519586929?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:15","pubTimestamp":1741896900,"startTime":"0","endTime":"0","summary":"Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights. -- Recently announced positive data from pivotal randomized,placebo-controlled phase 3 clinical trial of CAN-2409 in. prostate cancer underway, with submission expected in Q4 2026. Dr. Tak continued, \"We enter 2025 well-resourced with a clear direction and mandate. Our primary focus for the year is working toward readiness to submit CAN-2409's BLA for prostate cancer, a key opportunity to address a very significant unmet need and opportunity for value creation. In addition, we continue to explore the efficacy of CAN-2409 in other indications, as evidenced by our recently disclosed positive final overall survival data for CAN-2409 in a randomized controlled phase 2a trial in borderline resectable pancreatic cancer. This result has triggered enabling work, which will include scientific advisory boards and engagement with the FDA, to get ready for a larger, late-stage, randomiz","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4595","BK4600","SITC","BK4166","LU1791807156.HKD","LU2360107671.USD","LENZ","03160","BK4099","TM","BK4585","BK4526","BK4588","BK4139","LU1861220207.SGD","LU1861217088.USD","BK4080","LU1668664300.SGD","BK4231","CADL","BK4170","BK4604","BK4555","LU0106831901.USD","BK4539","DFS"],"gpt_icon":1}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":95,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CADL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-09-08","symbol":"CADL","fiscalQuarterEnding":"2021/06","expectedEps":-0.36,"name":null,"time":"","type":"earning","dateTimestamp":1631073600000,"reportTimeType":"","actualEps":-0.31}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CADL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CADL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1740283200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CADL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CADL","date":"2025-04-17","current":-3.878004,"percent":0.491749,"low":-19.090472,"twenty":-5.67132,"median":-3.849493,"eighty":-1.574824,"high":-0.606705,"avg":-4.072945,"sd":2.563575,"marketCap":213976633},"quantilePoints":[{"date":"2021-07-23","current":-17.029133,"twenty":-17.029085,"median":-17.029014,"eighty":-11.621563,"marketCap":347155900},{"date":"2021-07-30","current":-10.349763,"twenty":-17.029085,"median":-10.15204,"eighty":-9.455238,"marketCap":210990265},{"date":"2021-08-06","current":-10.267947,"twenty":-14.357314,"median":-10.227038,"eighty":-9.708868,"marketCap":209322358},{"date":"2021-08-13","current":-10.349763,"twenty":-11.418829,"median":-10.322491,"eighty":-10.063405,"marketCap":210990265},{"date":"2021-08-20","current":-8.865134,"twenty":-11.028838,"median":-10.227038,"eighty":-9.408343,"marketCap":180724622},{"date":"2021-08-27","current":-11.257313,"twenty":-11.217913,"median":-10.322491,"eighty":-9.474894,"marketCap":229491584},{"date":"2021-09-03","current":-11.468388,"twenty":-11.293511,"median":-10.349763,"eighty":-9.703414,"marketCap":233794551},{"date":"2021-09-10","current":-9.040742,"twenty":-11.303556,"median":-10.349763,"eighty":-9.401791,"marketCap":312719277},{"date":"2021-09-17","current":-6.502699,"twenty":-11.262165,"median":-10.281583,"eighty":-9.046428,"marketCap":224928361},{"date":"2021-09-24","current":-8.236199,"twenty":-11.24887,"median":-10.227038,"eighty":-8.247811,"marketCap":284890131},{"date":"2021-10-01","current":-8.708972,"twenty":-11.206655,"median":-9.947499,"eighty":-8.297577,"marketCap":301243341},{"date":"2021-10-08","current":-8.908034,"twenty":-11.170069,"median":-9.428,"eighty":-8.297577,"marketCap":308128903},{"date":"2021-10-15","current":-8.153257,"twenty":-11.133483,"median":-9.293717,"eighty":-8.209657,"marketCap":282021146},{"date":"2021-10-22","current":-7.987371,"twenty":-11.023724,"median":-9.069173,"eighty":-8.121739,"marketCap":276283178},{"date":"2021-10-29","current":-9.314453,"twenty":-10.93648,"median":-9.202481,"eighty":-8.133351,"marketCap":322186925},{"date":"2021-11-05","current":-8.974388,"twenty":-10.713478,"median":-9.297864,"eighty":-8.159892,"marketCap":310424090},{"date":"2021-11-12","current":-6.56858,"twenty":-10.611575,"median":-9.277128,"eighty":-8.159892,"marketCap":316592406},{"date":"2021-11-19","current":-6.470364,"twenty":-10.349763,"median":-9.115391,"eighty":-8.061219,"marketCap":311858582},{"date":"2021-11-26","current":-5.821541,"twenty":-10.349763,"median":-9.069173,"eighty":-7.987371,"marketCap":280586654},{"date":"2021-12-03","current":-5.595347,"twenty":-10.349763,"median":-8.982682,"eighty":-6.900824,"marketCap":269684514},{"date":"2021-12-10","current":-5.250102,"twenty":-10.295219,"median":-8.865134,"eighty":-6.502699,"marketCap":253044406},{"date":"2021-12-17","current":-3.773883,"twenty":-10.267947,"median":-8.688236,"eighty":-6.309646,"marketCap":181893598},{"date":"2021-12-23","current":-5.000097,"twenty":-10.23522,"median":-8.576264,"eighty":-5.981068,"marketCap":240994672},{"date":"2021-12-31","current":-4.654852,"twenty":-10.227038,"median":-8.518204,"eighty":-5.90437,"marketCap":224354564},{"date":"2022-01-07","current":-4.017935,"twenty":-10.227038,"median":-8.385496,"eighty":-5.676301,"marketCap":193656433},{"date":"2022-01-14","current":-3.72031,"twenty":-10.008861,"median":-8.236199,"eighty":-5.200101,"marketCap":179311512},{"date":"2022-01-21","current":-3.60126,"twenty":-9.946135,"median":-8.186434,"eighty":-4.754854,"marketCap":173573544},{"date":"2022-01-28","current":-2.672671,"twenty":-9.898373,"median":-8.124227,"eighty":-4.622709,"marketCap":128817390},{"date":"2022-02-04","current":-2.476238,"twenty":-9.775613,"median":-8.053725,"eighty":-4.401276,"marketCap":119349742},{"date":"2022-02-11","current":-2.375046,"twenty":-9.707601,"median":-7.999813,"eighty":-4.161985,"marketCap":114472469},{"date":"2022-02-18","current":-2.506001,"twenty":-9.629635,"median":-6.99206,"eighty":-4.070317,"marketCap":120784234},{"date":"2022-02-25","current":-2.648861,"twenty":-9.566016,"median":-6.900824,"eighty":-3.991744,"marketCap":127669796},{"date":"2022-03-04","current":-2.464333,"twenty":-9.542501,"median":-6.701524,"eighty":-3.776264,"marketCap":118775945},{"date":"2022-03-11","current":-2.291711,"twenty":-9.53508,"median":-6.470364,"eighty":-3.64888,"marketCap":110455891},{"date":"2022-03-18","current":-2.809578,"twenty":-9.489262,"median":-6.339408,"eighty":-2.81434,"marketCap":135416054},{"date":"2022-03-25","current":-2.708386,"twenty":-9.414896,"median":-6.142976,"eighty":-2.740529,"marketCap":130538781},{"date":"2022-04-01","current":-4.169755,"twenty":-9.36956,"median":-5.967377,"eighty":-2.740529,"marketCap":150628212},{"date":"2022-04-08","current":-3.883828,"twenty":-9.324406,"median":-5.922101,"eighty":-2.763149,"marketCap":140299420},{"date":"2022-04-14","current":-4.1221,"twenty":-9.314453,"median":-5.821541,"eighty":-2.795292,"marketCap":148906746},{"date":"2022-04-22","current":-3.875886,"twenty":-9.311135,"median":-5.645943,"eighty":-2.811959,"marketCap":140012509},{"date":"2022-04-29","current":-2.843375,"twenty":-9.296205,"median":-5.369152,"eighty":-2.822674,"marketCap":102714095},{"date":"2022-05-06","current":-2.954569,"twenty":-9.284593,"median":-4.991168,"eighty":-2.829035,"marketCap":106730847},{"date":"2022-05-13","current":-3.529293,"twenty":-9.234828,"median":-4.74414,"eighty":-2.829035,"marketCap":114772604},{"date":"2022-05-20","current":-3.096954,"twenty":-9.115391,"median":-4.651876,"eighty":-2.837021,"marketCap":100712960},{"date":"2022-05-27","current":-3.749874,"twenty":-9.108756,"median":-4.535802,"eighty":-2.837021,"marketCap":121945891},{"date":"2022-06-03","current":-3.326359,"twenty":-9.082214,"median":-4.43461,"eighty":-2.843375,"marketCap":108173179},{"date":"2022-06-10","current":-2.938136,"twenty":-9.069173,"median":-4.363766,"eighty":-2.863151,"marketCap":95548192},{"date":"2022-06-17","current":-3.061662,"twenty":-9.040742,"median":-4.226272,"eighty":-2.898972,"marketCap":99565233},{"date":"2022-06-24","current":-3.088131,"twenty":-9.00093,"median":-4.166747,"eighty":-2.91168,"marketCap":100426028},{"date":"2022-07-01","current":-2.832258,"twenty":-8.977706,"median":-4.148404,"eighty":-2.891808,"marketCap":92105014},{"date":"2022-07-08","current":-3.088131,"twenty":-8.934576,"median":-4.117637,"eighty":-2.884644,"marketCap":100426028},{"date":"2022-07-15","current":-2.94696,"twenty":-8.882294,"median":-4.074446,"eighty":-2.861381,"marketCap":95835124},{"date":"2022-07-22","current":-2.823434,"twenty":-8.771437,"median":-4.04221,"eighty":-2.861381,"marketCap":91818083},{"date":"2022-07-29","current":-2.735202,"twenty":-8.708972,"median":-4.00603,"eighty":-2.861381,"marketCap":88948768},{"date":"2022-08-05","current":-5.162167,"twenty":-8.684089,"median":-3.988621,"eighty":-2.861381,"marketCap":101121681},{"date":"2022-08-12","current":-4.963054,"twenty":-8.617735,"median":-4.017935,"eighty":-2.871085,"marketCap":97221273},{"date":"2022-08-19","current":-5.10317,"twenty":-8.574605,"median":-4.05459,"eighty":-2.876374,"marketCap":99966005},{"date":"2022-08-26","current":-4.970429,"twenty":-8.548064,"median":-4.089365,"eighty":-2.889933,"marketCap":97365733},{"date":"2022-09-02","current":-4.822938,"twenty":-8.52484,"median":-4.132518,"eighty":-2.906589,"marketCap":94476542},{"date":"2022-09-09","current":-6.017611,"twenty":-8.511568,"median":-4.154356,"eighty":-2.912943,"marketCap":117878988},{"date":"2022-09-16","current":-4.79344,"twenty":-8.485027,"median":-4.169755,"eighty":-2.920639,"marketCap":93898704},{"date":"2022-09-23","current":-4.911433,"twenty":-8.400426,"median":-4.300679,"eighty":-2.929313,"marketCap":96210056},{"date":"2022-09-30","current":-4.631201,"twenty":-8.304212,"median":-4.415969,"eighty":-2.932842,"marketCap":90720594},{"date":"2022-10-07","current":-4.424714,"twenty":-8.271035,"median":-4.449491,"eighty":-2.941666,"marketCap":86675727},{"date":"2022-10-14","current":-3.746258,"twenty":-8.222928,"median":-4.424714,"eighty":-2.950004,"marketCap":73385448},{"date":"2022-10-21","current":-2.654829,"twenty":-8.196387,"median":-4.363766,"eighty":-2.941666,"marketCap":52005436},{"date":"2022-10-28","current":-2.861315,"twenty":-8.173163,"median":-4.250082,"eighty":-2.920639,"marketCap":56050303},{"date":"2022-11-04","current":-2.286102,"twenty":-8.143304,"median":-4.179242,"eighty":-2.876374,"marketCap":44782458},{"date":"2022-11-11","current":-3.866531,"twenty":-8.125056,"median":-4.154842,"eighty":-2.868316,"marketCap":46843024},{"date":"2022-11-18","current":-4.221416,"twenty":-8.108526,"median":-4.168251,"eighty":-2.876188,"marketCap":51142457},{"date":"2022-11-25","current":-4.364515,"twenty":-8.0837,"median":-4.160794,"eighty":-2.876374,"marketCap":52876100},{"date":"2022-12-02","current":-4.483764,"twenty":-8.046299,"median":-4.166747,"eighty":-2.880894,"marketCap":54320802},{"date":"2022-12-09","current":-4.98461,"twenty":-8.015727,"median":-4.168251,"eighty":-2.901511,"marketCap":60388551},{"date":"2022-12-16","current":-3.935218,"twenty":-8.007277,"median":-4.173717,"eighty":-2.912305,"marketCap":47675172},{"date":"2022-12-23","current":-3.625171,"twenty":-7.985712,"median":-4.160794,"eighty":-2.917748,"marketCap":43918946},{"date":"2022-12-30","current":-4.269116,"twenty":-7.979077,"median":-4.154356,"eighty":-2.929313,"marketCap":51720338},{"date":"2023-01-06","current":-4.722262,"twenty":-7.189463,"median":-4.168251,"eighty":-2.929313,"marketCap":57210207},{"date":"2023-01-13","current":-4.96076,"twenty":-6.925706,"median":-4.173717,"eighty":-2.936371,"marketCap":60099611},{"date":"2023-01-20","current":-5.676255,"twenty":-6.904142,"median":-4.197566,"eighty":-2.94343,"marketCap":68767824},{"date":"2023-01-27","current":-6.367899,"twenty":-6.895847,"median":-4.223844,"eighty":-2.948669,"marketCap":77147097},{"date":"2023-02-03","current":-5.771654,"twenty":-6.857693,"median":-4.269116,"eighty":-2.949809,"marketCap":69923586},{"date":"2023-02-10","current":-4.89088,"twenty":-6.674936,"median":-4.30489,"eighty":-2.952665,"marketCap":59253016},{"date":"2023-02-17","current":-5.00846,"twenty":-6.529051,"median":-4.364515,"eighty":-2.960591,"marketCap":60677492},{"date":"2023-02-24","current":-4.674563,"twenty":-6.496479,"median":-4.388365,"eighty":-2.964606,"marketCap":56632326},{"date":"2023-03-03","current":-4.102167,"twenty":-6.480434,"median":-4.382311,"eighty":-2.964606,"marketCap":49697755},{"date":"2023-03-10","current":-3.863669,"twenty":-6.429887,"median":-4.376257,"eighty":-2.968135,"marketCap":46808351},{"date":"2023-03-17","current":-3.410523,"twenty":-6.369171,"median":-4.334045,"eighty":-2.975416,"marketCap":41318482},{"date":"2023-03-24","current":-3.553622,"twenty":-6.368662,"median":-4.292966,"eighty":-2.983468,"marketCap":43052125},{"date":"2023-03-31","current":-2.077351,"twenty":-6.367899,"median":-4.27317,"eighty":-2.975416,"marketCap":39041743},{"date":"2023-04-06","current":-2.185066,"twenty":-6.356248,"median":-4.247674,"eighty":-2.964606,"marketCap":41066130},{"date":"2023-04-14","current":-2.092739,"twenty":-6.281074,"median":-4.221416,"eighty":-2.94753,"marketCap":39330941},{"date":"2023-04-21","current":-2.169678,"twenty":-6.162024,"median":-4.193148,"eighty":-2.917748,"marketCap":40776932},{"date":"2023-04-28","current":-2.056424,"twenty":-6.140023,"median":-4.173717,"eighty":-2.876374,"marketCap":38648434},{"date":"2023-05-05","current":-2.615924,"twenty":-6.106089,"median":-4.160794,"eighty":-2.861315,"marketCap":49163677},{"date":"2023-05-12","current":-2.6467,"twenty":-6.010541,"median":-4.149867,"eighty":-2.837021,"marketCap":49742073},{"date":"2023-05-19","current":-1.85037,"twenty":-5.981068,"median":-4.134477,"eighty":-2.824234,"marketCap":49432631},{"date":"2023-05-26","current":-1.580495,"twenty":-5.973535,"median":-4.113175,"eighty":-2.802319,"marketCap":42222922},{"date":"2023-06-02","current":-1.634621,"twenty":-5.962452,"median":-4.102167,"eighty":-2.791721,"marketCap":43668913},{"date":"2023-06-09","current":-1.721224,"twenty":-5.958449,"median":-4.083841,"eighty":-2.738148,"marketCap":45982497},{"date":"2023-06-16","current":-1.548019,"twenty":-5.940591,"median":-4.074446,"eighty":-2.708386,"marketCap":41355328},{"date":"2023-06-23","current":-1.299037,"twenty":-5.925799,"median":-4.054468,"eighty":-2.678393,"marketCap":34703772},{"date":"2023-06-30","current":-1.342338,"twenty":-5.868908,"median":-4.041745,"eighty":-2.666718,"marketCap":35860564},{"date":"2023-07-07","current":-1.331513,"twenty":-5.828684,"median":-4.017935,"eighty":-2.648861,"marketCap":35571366},{"date":"2023-07-14","current":-1.299037,"twenty":-5.817375,"median":-4.000526,"eighty":-2.625586,"marketCap":34703772},{"date":"2023-07-21","current":-1.384124,"twenty":-5.795337,"median":-3.98222,"eighty":-2.553621,"marketCap":36976869},{"date":"2023-07-28","current":-1.169133,"twenty":-5.762114,"median":-3.959068,"eighty":-2.526239,"marketCap":31233394},{"date":"2023-08-04","current":-1.147483,"twenty":-5.747804,"median":-3.935218,"eighty":-2.502429,"marketCap":30654998},{"date":"2023-08-11","current":-0.95261,"twenty":-5.736822,"median":-3.883828,"eighty":-2.469095,"marketCap":30654998},{"date":"2023-08-18","current":-1.015518,"twenty":-5.710825,"median":-3.867944,"eighty":-2.435835,"marketCap":32679385},{"date":"2023-08-25","current":-1.159309,"twenty":-5.688425,"median":-3.851744,"eighty":-2.416215,"marketCap":37306554},{"date":"2023-09-01","current":-1.0964,"twenty":-5.652405,"median":-3.83936,"eighty":-2.375046,"marketCap":35282168},{"date":"2023-09-08","current":-1.055959,"twenty":-5.61663,"median":-3.82029,"eighty":-2.3156,"marketCap":33980776},{"date":"2023-09-15","current":-1.087414,"twenty":-5.599604,"median":-3.776859,"eighty":-2.275044,"marketCap":34992970},{"date":"2023-09-22","current":-1.024505,"twenty":-5.583753,"median":-3.749874,"eighty":-2.184625,"marketCap":32968583},{"date":"2023-09-27","current":-0.898689,"twenty":-5.570863,"median":-3.746258,"eighty":-2.179463,"marketCap":28919810},{"date":"2023-10-06","current":-0.772872,"twenty":-5.526576,"median":-3.732215,"eighty":-2.15429,"marketCap":24871036},{"date":"2023-10-13","current":-0.80882,"twenty":-5.509306,"median":-3.672871,"eighty":-2.12967,"marketCap":26027829},{"date":"2023-10-20","current":-0.80891,"twenty":-5.504536,"median":-3.635364,"eighty":-2.092739,"marketCap":26030720},{"date":"2023-10-27","current":-0.772962,"twenty":-5.499766,"median":-3.625171,"eighty":-2.083506,"marketCap":24873928},{"date":"2023-11-03","current":-0.772872,"twenty":-5.475291,"median":-3.577471,"eighty":-2.065041,"marketCap":24871036},{"date":"2023-11-10","current":-0.788055,"twenty":-5.430485,"median":-3.553622,"eighty":-1.861913,"marketCap":25160234},{"date":"2023-11-17","current":-0.932985,"twenty":-5.404956,"median":-3.529772,"eighty":-1.801331,"marketCap":29787404},{"date":"2023-11-24","current":-0.887241,"twenty":-5.369152,"median":-3.529293,"eighty":-1.721224,"marketCap":28326953},{"date":"2023-12-01","current":-0.814324,"twenty":-5.366446,"median":-3.508229,"eighty":-1.688748,"marketCap":25998909},{"date":"2023-12-08","current":-0.815229,"twenty":-5.366207,"median":-3.432237,"eighty":-1.656272,"marketCap":26027829},{"date":"2023-12-15","current":-1.19567,"twenty":-5.309657,"median":-3.401356,"eighty":-1.59132,"marketCap":38174149},{"date":"2023-12-22","current":-1.014508,"twenty":-5.294908,"median":-3.364254,"eighty":-1.548019,"marketCap":32390187},{"date":"2023-12-29","current":-1.259076,"twenty":-5.280448,"median":-3.357826,"eighty":-1.472242,"marketCap":40198535},{"date":"2024-01-05","current":-1.349658,"twenty":-5.266667,"median":-3.338973,"eighty":-1.384427,"marketCap":43090516},{"date":"2024-01-12","current":-1.159437,"twenty":-5.249473,"median":-3.33077,"eighty":-1.350359,"marketCap":37017356},{"date":"2024-01-19","current":-1.168495,"twenty":-5.246958,"median":-3.320741,"eighty":-1.342338,"marketCap":37306554},{"date":"2024-01-26","current":-1.141321,"twenty":-5.176916,"median":-3.299889,"eighty":-1.331513,"marketCap":36438960},{"date":"2024-02-02","current":-1.19567,"twenty":-5.162167,"median":-3.216068,"eighty":-1.299037,"marketCap":38174149},{"date":"2024-02-09","current":-1.14585,"twenty":-5.162167,"median":-3.132247,"eighty":-1.277386,"marketCap":36583559},{"date":"2024-02-16","current":-1.57611,"twenty":-5.162167,"median":-3.097243,"eighty":-1.277386,"marketCap":50320469},{"date":"2024-02-23","current":-1.569679,"twenty":-5.162167,"median":-3.092543,"eighty":-1.291724,"marketCap":50115138},{"date":"2024-03-01","current":-1.684807,"twenty":-5.162167,"median":-3.088131,"eighty":-1.298291,"marketCap":53790846},{"date":"2024-03-08","current":-1.38589,"twenty":-5.162167,"median":-3.070485,"eighty":-1.299037,"marketCap":44247309},{"date":"2024-03-15","current":-1.413064,"twenty":-5.150368,"median":-3.052838,"eighty":-1.299037,"marketCap":45114903},{"date":"2024-03-22","current":-1.313425,"twenty":-5.123819,"median":-3.046946,"eighty":-1.299037,"marketCap":41933724},{"date":"2024-03-28","current":-1.173898,"twenty":-5.117919,"median":-3.034152,"eighty":-1.299037,"marketCap":44536507},{"date":"2024-04-05","current":-4.950679,"twenty":-5.109483,"median":-3.026369,"eighty":-1.299037,"marketCap":187823795},{"date":"2024-04-12","current":-5.631397,"twenty":-5.117919,"median":-3.042975,"eighty":-1.299037,"marketCap":213649567},{"date":"2024-04-19","current":-4.223548,"twenty":-5.117919,"median":-3.052838,"eighty":-1.299037,"marketCap":160237175},{"date":"2024-04-26","current":-4.973885,"twenty":-5.109483,"median":-3.061662,"eighty":-1.299347,"marketCap":188704219},{"date":"2024-05-03","current":-6.520972,"twenty":-5.125283,"median":-3.079308,"eighty":-1.304195,"marketCap":247399155},{"date":"2024-05-10","current":-7.712229,"twenty":-5.162167,"median":-3.088131,"eighty":-1.310971,"marketCap":292594255},{"date":"2024-05-17","current":-9.974919,"twenty":-5.162167,"median":-3.096954,"eighty":-1.313425,"marketCap":372712843},{"date":"2024-05-24","current":-8.396211,"twenty":-5.258384,"median":-3.119013,"eighty":-1.317783,"marketCap":313724432},{"date":"2024-05-31","current":-6.862025,"twenty":-5.343587,"median":-3.182392,"eighty":-1.325018,"marketCap":256399581},{"date":"2024-06-07","current":-5.670086,"twenty":-5.42634,"median":-3.264596,"eighty":-1.335843,"marketCap":211862755},{"date":"2024-06-14","current":-6.004557,"twenty":-5.504536,"median":-3.308712,"eighty":-1.342338,"marketCap":224360277},{"date":"2024-06-21","current":-4.762235,"twenty":-5.509306,"median":-3.326359,"eighty":-1.342338,"marketCap":177940909},{"date":"2024-06-28","current":-4.690563,"twenty":-5.522258,"median":-3.326359,"eighty":-1.342338,"marketCap":175262869},{"date":"2024-07-05","current":-5.025034,"twenty":-5.509306,"median":-3.338973,"eighty":-1.342338,"marketCap":187760391},{"date":"2024-07-12","current":-4.70649,"twenty":-5.504536,"median":-3.357826,"eighty":-1.342338,"marketCap":175857989},{"date":"2024-07-15","current":-4.857798,"twenty":-5.499766,"median":-3.362823,"eighty":-1.342338,"marketCap":181511630},{"date":"2024-08-02","current":-4.411836,"twenty":-5.494996,"median":-3.363538,"eighty":-1.342338,"marketCap":164848267},{"date":"2024-08-09","current":-4.372018,"twenty":-5.466272,"median":-3.396944,"eighty":-1.34673,"marketCap":163360467},{"date":"2024-08-16","current":-3.453151,"twenty":-5.44217,"median":-3.408145,"eighty":-1.349658,"marketCap":172616100},{"date":"2024-08-23","current":-3.408221,"twenty":-5.422196,"median":-3.396944,"eighty":-1.349658,"marketCap":170370165},{"date":"2024-08-30","current":-4.095,"twenty":-5.387054,"median":-3.409372,"eighty":-1.351761,"marketCap":204700877},{"date":"2024-09-06","current":-4.050071,"twenty":-5.36807,"median":-3.442694,"eighty":-1.353163,"marketCap":202454942},{"date":"2024-09-13","current":-4.216952,"twenty":-5.36635,"median":-3.505922,"eighty":-1.353163,"marketCap":210796984},{"date":"2024-09-20","current":-4.929405,"twenty":-5.360341,"median":-3.529293,"eighty":-1.353378,"marketCap":246411087},{"date":"2024-09-27","current":-4.499366,"twenty":-5.334788,"median":-3.529772,"eighty":-1.355707,"marketCap":224914286},{"date":"2024-10-04","current":-4.306811,"twenty":-5.303757,"median":-3.553622,"eighty":-1.358716,"marketCap":215288853},{"date":"2024-10-11","current":-3.857516,"twenty":-5.285268,"median":-3.577471,"eighty":-1.358716,"marketCap":192829509},{"date":"2024-10-18","current":-3.767657,"twenty":-5.262526,"median":-3.635364,"eighty":-1.358716,"marketCap":188337640},{"date":"2024-10-25","current":-3.54301,"twenty":-5.248844,"median":-3.645706,"eighty":-1.365962,"marketCap":177107969},{"date":"2024-10-31","current":-3.472406,"twenty":-5.23295,"median":-3.625171,"eighty":-1.37829,"marketCap":173578643},{"date":"2024-11-08","current":-3.267014,"twenty":-5.173966,"median":-3.585915,"eighty":-1.384427,"marketCap":163311514},{"date":"2024-11-15","current":-2.675239,"twenty":-5.162167,"median":-3.553622,"eighty":-1.385689,"marketCap":139644809},{"date":"2024-11-22","current":-2.572585,"twenty":-5.162167,"median":-3.539801,"eighty":-1.39017,"marketCap":134286345},{"date":"2024-11-29","current":-2.927209,"twenty":-5.162167,"median":-3.529772,"eighty":-1.40729,"marketCap":152797401},{"date":"2024-12-06","current":-3.048528,"twenty":-5.162167,"median":-3.529293,"eighty":-1.413064,"marketCap":159130131},{"date":"2024-12-13","current":-6.097057,"twenty":-5.162167,"median":-3.529293,"eighty":-1.422122,"marketCap":318260262},{"date":"2024-12-20","current":-6.1966,"twenty":-5.162167,"median":-3.529772,"eighty":-1.422122,"marketCap":323456348},{"date":"2024-12-27","current":-5.705103,"twenty":-5.165117,"median":-3.536591,"eighty":-1.429368,"marketCap":297800674},{"date":"2025-01-03","current":-5.593116,"twenty":-5.248216,"median":-3.553622,"eighty":-1.447485,"marketCap":291955077},{"date":"2025-01-10","current":-5.431358,"twenty":-5.285268,"median":-3.574075,"eighty":-1.465601,"marketCap":283511438},{"date":"2025-01-17","current":-4.784323,"twenty":-5.262526,"median":-3.597809,"eighty":-1.483717,"marketCap":249736879},{"date":"2025-01-24","current":-5.744886,"twenty":-5.343165,"median":-3.635364,"eighty":-1.498778,"marketCap":299877298},{"date":"2025-01-31","current":-5.663514,"twenty":-5.368611,"median":-3.645706,"eighty":-1.516787,"marketCap":295629744},{"date":"2025-02-07","current":-6.347041,"twenty":-5.410779,"median":-3.664102,"eighty":-1.522683,"marketCap":331309196},{"date":"2025-02-14","current":-7.177039,"twenty":-5.433975,"median":-3.72031,"eighty":-1.527258,"marketCap":374634245},{"date":"2025-02-21","current":-9.93556,"twenty":-5.453482,"median":-3.74442,"eighty":-1.53082,"marketCap":518626318},{"date":"2025-02-28","current":-6.99802,"twenty":-5.509306,"median":-3.748402,"eighty":-1.539878,"marketCap":365289626},{"date":"2025-03-07","current":-6.387727,"twenty":-5.565867,"median":-3.750073,"eighty":-1.548019,"marketCap":333432973},{"date":"2025-03-14","current":-6.797208,"twenty":-5.598413,"median":-3.77077,"eighty":-1.557994,"marketCap":375049552},{"date":"2025-03-21","current":-7.06259,"twenty":-5.663514,"median":-3.779835,"eighty":-1.557994,"marketCap":389692545},{"date":"2025-03-28","current":-5.949697,"twenty":-5.696539,"median":-3.824165,"eighty":-1.56967,"marketCap":328286447},{"date":"2025-04-04","current":-4.494376,"twenty":-5.693977,"median":-3.83936,"eighty":-1.56967,"marketCap":247986165},{"date":"2025-04-11","current":-4.083461,"twenty":-5.676255,"median":-3.839819,"eighty":-1.569679,"marketCap":225313144},{"date":"2025-04-17","current":-3.878004,"twenty":-5.67132,"median":-3.849493,"eighty":-1.574824,"marketCap":213976633}],"updateTime":1745273683095}}}